Nemo and BEAT-Mesothelioma UK trials

The NEMO clinical trial, a multicentre, prospective, double blinded, randomised, two-arm phase II trial aiming to evaluate nintedanib as switch maintenance treatment, has been open for a while and is still looking to recruit patients.

Open centres in the UK are Wythenshawe Hospital, Manchester, Royal Marsden Hospitals, Chelsea, Sutton and Kingston, Weston Park Hospital, Sheffield, and South Tyneside District Hospital, South Shields.

The BEAT-Meso clinical trial is a new trial which opened in August at the Royal Marsden Hospitals (Chelsea and Sutton), and Truro Hospital. The team is looking for newly diagnosed mesothelioma patients to take part. The aim of this clinical trial is to assess the effect of treatment with an immunotherapy monoclonal antibody called atezolizumab in patients diagnosed with malignant pleural mesothelioma.

The efficacy (whether the treatment works), safety and tolerability (side effects of treatment) of atezolizumab plus bevacizumab in combination with standard chemotherapy versus bevacizumab in combination with standard chemotherapy will be investigated.

Sites will also be set up at Maidstone, Sheffield, Guys, Addenbrookes, Plymouth, Clatterbridge and Wythenshawe. Patients should speak to their oncologist about a referral for clinical trials.

Introducing the new Health Companion portal

Working in collaboration with DaSH-Global, a pharmaceutical manufacturing company, we have developed a new digital patient portal known as the ‘Health Companion’. The new system will allow patients to submit data regarding their quality of life and experiences in the...

Join our Asbestos Commercial Club

If you are a business involved in the management of asbestos or the diseases it causes, why not join our Asbestos Commercial Club (MUKACC) to support the vital work that we do? Joining MUKACC can be a great morale booster for your staff, encouraging them to get...

CEO Liz Darlison to speak at the European Asbestos Conference

Mesothelioma UK’s CEO, Liz Darlison, has been confirmed as a speaker at the European Asbestos Forum Conference (EAF). The event will take place from 10-11 November in Amsterdam, in the Netherlands, where she will deliver a talk entitled, Establishing a National...

Mesothelioma National Statistics

The Health and Safety Executive has been publishing statistics on annual mesothelioma deaths in Great Britain on a consistent basis for 50 years. Detailed statistical tables and commentary are available as part of HSE’s National Statistics web pages here. The data...